196 related articles for article (PubMed ID: 7357541)
1. Effect of 2,3-dihydro-1 H-imidazo[1,2-b]pyrazole on the proliferation of mouse leukemic and normal cells in vivo.
Ganapathi R; Krishan A
Cancer Res; 1980 Apr; 40(4):1103-8. PubMed ID: 7357541
[TBL] [Abstract][Full Text] [Related]
2. Studies on the pharmacology and cytokinetics of 2,3-dihydro-1H-imadazo[1,2-b]pyrazole (NSC 51143) with P815 mastocytoma cells.
Allen LM; Thornthwaite JT
Cancer Res; 1980 Nov; 40(11):4059-63. PubMed ID: 6781739
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle synchronization of human lymphoid cells in vitro by 2,3-dihydro-1h-imidazo[1,2-b]pyrazole.
Krishan A; Paika D; Frei E
Cancer Res; 1976 Jan; 36(1):138-42. PubMed ID: 1247993
[TBL] [Abstract][Full Text] [Related]
4. Response of transplantable tumors in mice and of macromolecular synthesis to 17 beta-acetamido-3-aza-A-homo-4 alpha-androsten-4-one.
Athanasiou C; Catsoulacos P; Papageorgiou A; Athanasiou K
Cancer Invest; 1987; 5(4):301-7. PubMed ID: 3664333
[TBL] [Abstract][Full Text] [Related]
5. Biological characterization of a prolonged antileukemic effect of 5-azacytidine.
Presant CA; Valeriote F; Vietti TJ
Cancer Res; 1977 Feb; 37(2):376-81. PubMed ID: 64294
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
Lin TS; Fischer PH; Marsh JC; Prusoff WH
Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884
[TBL] [Abstract][Full Text] [Related]
7. [The effect of 3,4-disuccinyldianhydrogalactitol, N-nitrosourea and their combination on DNA synthesis in normal and mouse P388 tumor cells].
Sokolova IS; Veres Z; Jakus J; Otvos LL; Gorbacheva LB
Izv Akad Nauk SSSR Biol; 1989; (4):527-33. PubMed ID: 2794230
[TBL] [Abstract][Full Text] [Related]
8. In vivo antitumor activity of the bitter melon (Momordica charantia).
Jilka C; Strifler B; Fortner GW; Hays EF; Takemoto DJ
Cancer Res; 1983 Nov; 43(11):5151-5. PubMed ID: 6616452
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
Avramis VI; Plunkett W
Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic effect of the combination of 2,3-dihydro-1H-pyrazole[2,3a]imidazole plus deoxyadenosine/erythro-9-(2-hydroxyl-3-nonyl)adenine in mice with L1210 leukemia cells.
Matsumoto M; Weckbecker G; Cory JG
Cancer Commun; 1990; 2(1):1-6. PubMed ID: 2369548
[TBL] [Abstract][Full Text] [Related]
11. An in vitro assay for evaluating chemosensitivity of leukaemia cells: preclinical studies.
Menconi E; Lepri E; Bonmassar E; Frati L; Barzi A
Int J Tissue React; 1986; 8(6):485-92. PubMed ID: 3793386
[TBL] [Abstract][Full Text] [Related]
12. 7,8-dihydro-5H-isoindolo[1,2-b] [3]benzazepine-5-ones. Part 2: In vitro effect of derivatives substituted at position 7 on leukemia P 388 cells.
Fuska J; Fusková A; Proksa B
Pharmazie; 1982 Jun; 37(6):443-5. PubMed ID: 7122688
[TBL] [Abstract][Full Text] [Related]
13. In vivo antitumor activity of 4-amino 4-methyl 2-pentyne 1-al, an inhibitor of aldehyde dehydrogenase.
Quemener V; Quash G; Moulinoux JP; Penlap V; Ripoll H; Havouis R; Doutheau A; Goré J
In Vivo; 1989; 3(5):325-30. PubMed ID: 2519873
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
Guo QL; Wu MS; Chen Z
Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
[TBL] [Abstract][Full Text] [Related]
15. [Cytometric study of the effects of destruxin E on leukemic cells in mice].
Odier F; Vago P; Quiot JM; Devauchelle G; Bureau JP
C R Acad Sci III; 1987; 305(14):575-8. PubMed ID: 3121146
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor effect of 1,3,3,5,5-pentaziridino-1-thia-2,4,6-triaza-3,5- diphoshorine-1-oxide].
Kato T; Takamoto S; Ota K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3401-7. PubMed ID: 3789752
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of antileukemic activity of L-lysine-alpha oxidase from Trichoderma sp. in chemotherapeutic experiments].
Khaduev SKh; Glazkova TIu; Vesa VS; Laugalene NF; Puodzhiute SP; Denis GI; Iurchenko NIa; Berezov TT
Biull Eksp Biol Med; 1989 Oct; 108(10):476-7. PubMed ID: 2597765
[TBL] [Abstract][Full Text] [Related]
18. Histidinol-mediated enhancement of the specificity of two anticancer drugs in mice bearing leukemic bone marrow disease.
Warrington RC; Fang WD
J Natl Cancer Inst; 1985 May; 74(5):1071-7. PubMed ID: 3858576
[TBL] [Abstract][Full Text] [Related]
19. Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemia.
McGovren JP
Cancer Treat Rep; 1980; 64(4-5):727-9. PubMed ID: 6448690
[TBL] [Abstract][Full Text] [Related]
20. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
Rose WC; Schurig JE; Huftalen JB; Bradner WT
Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
